Total debt declined from $2.8B to $2.1B over ten quarters (D/E of 0.38), but equity has eroded to $3.6B as retained losses deepened to -$924.7M, with cash down 43% to $1.3B since 2023Q4.
Baozun Inc. (BZUN) balance sheet — 14-year assets, liabilities & shareholders' equity history
| Metric | TTM | Dec'25 | Dec'24 | Dec'23 | Dec'22 | Dec'21 | Dec'20 | Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 |
|---|
| Total Current Assets | 6.75B | 6.81B | 7.21B | 7.28B | 7.29B | 9.19B | 9.14B | 5.63B | 3.26B | 2.5B | 2.17B | 1.78B | 805.57M | 505.5M | 450.17M |
| Cash & Short-Term Investments | 2.9B | 2.8B | 2.92B | 3.07B | 3.1B | 4.69B | 5.17B | 2.35B | 570.73M | 613.37M | 1.01B | 884.63M | 240.75M | 194.13M | 270.75M |
| Cash Only | 1.28B | 1.05B | 1.64B | 2.35B | 2.21B | 4.69B | 3.72B | 1.51B | 514.12M | 297.1M | 968.12M | 834.67M | 240.75M | 194.13M | 270.75M |
| Short-Term Investments | 1.62B | 1.75B | 1.27B | 719.7M | 882.58M | 0 | 1.45B | 835.01M | 56.61M | 316.27M | 40M | 49.96M | 0 | 0 | 0 |
| Accounts Receivable | 2.12B | 2.18B | 2.41B | 2.66B | 2.73B | 2.72B | 2.56B | 2.12B | 1.62B | 1.2B | 745.78M | 494.34M | 269.33M | 126.65M | 79.76M |
| Days Sales Outstanding | 73.14 | 80.03 | 93.52 | 110.35 | 118.68 | 105.85 | 105.57 | 106.11 | 109.36 | 105.37 | 80.29 | 69.44 | 62.05 | 30.38 | 30.5 |
| Inventory | 1.12B | 1.25B | 1.52B | 1.35B | 1.3B | 1.6B | 1.31B | 1.1B | 817.54M | 476.42M | 387.79M | 368.69M | 288.47M | 176.03M | 91.92M |
| Days Inventory Outstanding | 97.97 | 93.15 | 112.54 | 100.57 | 95.12 | 98.33 | 85.47 | 90.15 | 90.5 | 63.57 | 57.47 | 65.3 | 83.95 | 47.17 | 38.12 |
| Other Current Assets | 618.88M | 582.7M | 158.94M | 93.37M | 83.69M | 65.88M | 35.36M | 39.77M | 221.14M | 190.37M | 14.64M | 23.84M | 4.46M | 7.05M | 6.55M |
| Total Non-Current Assets | 2.82B | 2.89B | 2.99B | 3.18B | 2.69B | 3.11B | 1.31B | 1.39B | 764.45M | 518.69M | 200.23M | 106.38M | 54.29M | 37.09M | 16.16M |
| Property, Plant & Equipment | 1.32B | 1.41B | 1.59B | 1.92B | 1.52B | 1.75B | 952.79M | 847.08M | 403.29M | 334.8M | 100.89M | 59.16M | 29.78M | 19.74M | 9.66M |
| Fixed Asset Turnover | 7.47x | 7.05x | 5.93x | 4.59x | 5.53x | 5.38x | 9.29x | 8.59x | 13.37x | 12.39x | 33.60x | 43.93x | 53.20x | 77.08x | 98.82x |
| Goodwill | 274.42M | 274.5M | 362.38M | 312.11M | 331.5M | 397.44M | 13.54M | 13.43M | 13.18M | 13.31M | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 309.97M | 323.13M | 357.28M | 306.07M | 306.27M | 394.75M | 146.05M | 149.43M | 132.57M | 66.92M | 26.98M | 20.11M | 14.46M | 10.11M | 5.17M |
| Long-Term Investments | 1.99B | 488.93M | 341.67M | 358.72M | 265.82M | 330.4M | 53.22M | 244.23M | 103.56M | 24.55M | 33.44M | 13.3M | 5.54M | 5.76M | 0 |
| Other Non-Current Assets | 170.17M | 107.56M | 107.32M | 83.68M | 103.1M | 128.29M | 92.87M | 83.13M | 73.71M | 63.39M | 26.58M | 13.82M | 4.5M | 1.48M | 1.33M |
| Total Assets | 9.57B | 9.7B | 10.21B | 10.46B | 9.98B | 12.3B | 10.45B | 7.02B | 4.02B | 3.01B | 2.37B | 1.89B | 859.86M | 542.59M | 466.33M |
| Asset Turnover | 1.07x | 1.03x | 0.92x | 0.84x | 0.84x | 0.76x | 0.85x | 1.04x | 1.34x | 1.38x | 1.43x | 1.38x | 1.84x | 2.80x | 2.05x |
| Asset Growth % | -6.92% | -4.99% | -2.45% | 4.86% | -18.91% | 17.73% | 48.87% | 74.59% | 33.43% | 27.26% | 25.47% | 119.51% | 58.47% | 16.35% | - |
| Total Current Liabilities | 3.56B | 3.65B | 3.75B | 3.75B | 3.63B | 4.77B | 2.19B | 2.3B | 1.75B | 1.16B | 796.23M | 654.13M | 387.75M | 229.79M | 144.86M |
| Accounts Payable | 453.59M | 466.38M | 620.64M | 562.92M | 467.92M | 493.5M | 420.64M | 867.71M | 887.56M | 590.36M | 526.44M | 457.09M | 295.66M | 177.45M | 57.12M |
| Days Payables Outstanding | 43.9 | 34.84 | 45.9 | 41.79 | 34.33 | 30.34 | 27.49 | 71.13 | 98.25 | 78.77 | 78.02 | 80.95 | 86.04 | 47.54 | 23.69 |
| Short-Term Debt | 1.7B | 1.78B | 1.93B | 1.95B | 1.71B | 3.09B | 664.48M | 768.73M | 463.6M | 222.58M | 115.14M | 31.06M | 16.75M | 0 | 48.89M |
| Deferred Revenue (Current) | 0 | 0 | 173.76M | 163.05M | 119.12M | 63.6M | 65.12M | 24.48M | 18.41M | 27.42M | 43.48M | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 1.37B | 1.36B | 732.73M | 748.86M | 986.97M | 758.16M | 615.32M | 404.76M | 194.21M | 211.87M | 69.01M | 136.18M | 57.48M | 40.44M | 31.33M |
| Current Ratio | 1.90x | 1.87x | 1.93x | 1.94x | 2.01x | 1.93x | 4.17x | 2.45x | 1.86x | 2.15x | 2.72x | 2.72x | 2.08x | 2.20x | 3.11x |
| Quick Ratio | 1.59x | 1.52x | 1.52x | 1.58x | 1.65x | 1.59x | 3.57x | 1.97x | 1.39x | 1.74x | 2.24x | 2.16x | 1.33x | 1.43x | 2.47x |
| Cash Conversion Cycle | 127.21 | 138.34 | 160.15 | 169.14 | 179.48 | 173.84 | 163.56 | 125.13 | 101.61 | 90.17 | 59.74 | 53.78 | 59.96 | 30 | 44.94 |
| Total Non-Current Liabilities | 501.6M | 554.71M | 678.82M | 863.79M | 753.52M | 1.06B | 2.13B | 2.15B | 72.17M | 3.75M | 0 | 0 | 0 | 0 | 0 |
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 1.76B | 1.84B | 68.85M | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 1.94B | 489.91M | 597.77M | 798.18M | 664.29M | 882.46M | 369.62M | 306.67M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 88.68M | 23M | 32.78M | 24.94M | 27.68M | 51.46M | 2.53M | 2.9M | 3.32M | 3.75M | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 54.42M | 41.81M | 48.27M | 40.67M | 61.55M | 125.84M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | 4.06B | 4.2B | 4.43B | 4.62B | 4.38B | 5.83B | 4.32B | 4.45B | 1.82B | 1.17B | 796.23M | 654.13M | 387.75M | 229.79M | 144.86M |
| Total Debt | 2.12B | 2.27B | 2.52B | 2.75B | 2.38B | 3.98B | 2.79B | 2.92B | 532.45M | 222.58M | 115.14M | 31.06M | 16.75M | 0 | 48.89M |
| Net Debt | 837.68M | 1.22B | 878.71M | 401.67M | 165.18M | -719.18M | -929.75M | 1.4B | 18.33M | -74.52M | -852.98M | -803.61M | -223.99M | -194.13M | -221.85M |
| Debt / Equity | 0.38x | 0.41x | 0.44x | 0.47x | 0.43x | 0.61x | 0.46x | 1.13x | 0.24x | 0.12x | 0.07x | 0.03x | 0.04x | - | 0.15x |
| Debt / EBITDA | 8.47x | 7.66x | 19.40x | 60.80x | 10.35x | 18.58x | 3.93x | 6.84x | 1.24x | 0.73x | 0.91x | 0.98x | - | - | - |
| Net Debt / EBITDA | 3.34x | 4.13x | 6.76x | 8.88x | 0.72x | -3.36x | -1.31x | 3.30x | 0.04x | -0.24x | -6.77x | -25.43x | - | - | - |
| Interest Coverage | -0.84x | -3.50x | -1.39x | -4.25x | -9.20x | -1.71x | 7.84x | 6.68x | 26.71x | 63.24x | - | - | -36.31x | -54.34x | -13.42x |
| Total Equity | 5.52B | 5.5B | 5.78B | 5.85B | 5.59B | 6.47B | 6.13B | 2.57B | 2.2B | 1.85B | 1.57B | 1.23B | 472.11M | 312.79M | 321.47M |
| Equity Growth % | -15.7% | -4.93% | -1.11% | 4.47% | -13.58% | 5.62% | 138.31% | 17.01% | 18.95% | 17.55% | 27.45% | 161.25% | 50.93% | -2.7% | - |
| Book Value per Share | 93.62 | 95.03 | 96.61 | 98.31 | 91.67 | 89.85 | 96.37 | 43.17 | 36.81 | 31.51 | 28.80 | 23.02 | 9.72 | 6.44 | 6.62 |
| Total Shareholders' Equity | 3.64B | 3.64B | 3.91B | 4.09B | 4.03B | 4.89B | 6.1B | 2.54B | 2.18B | 1.83B | 1.57B | 1.23B | 472.11M | 312.79M | 321.47M |
| Common Stock | 101.03K | 101.06K | 102.99K | 100.88K | 122.22K | 132.84K | 144.68K | 113.77K | 106.14K | 104.2K | 99.99K | 92.91K | 68.98K | 18.38K | 0 |
| Retained Earnings | -924.65M | -934.48M | -691.74M | -506.01M | -224.89M | 424.63M | 949.91M | 520.38M | 245.05M | -25.29M | -233.86M | -320.22M | -322.46M | -237.19M | -144.99M |
| Treasury Stock | -89.95M | -90.7M | -95.5M | 0 | -820.64M | -385.49M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 4.56M | 27.51M | 54.57M | 32.21M | 15.45M | -102.48M | -48.65M | 28.08M | 29.26M | 10.11M | 44.35M | 19.2M | 1.19M | -45.94K | 0 |
| Minority Interest | 1.88B | 1.85B | 1.87B | 1.75B | 1.57B | 1.58B | 31.51M | 30.71M | 17.5M | 17.62M | 0 | 0 | 0 | 0 | 0 |
Quick answers to the most common questions about buying BZUN stock.
As of 2025, Baozun Inc. (BZUN) had total assets of $9.70B including $6.81B in current assets.
Baozun Inc. (BZUN) carries total debt of $2.27B, offset by $2.80B in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.
Baozun Inc. (BZUN) has total shareholders' equity (book value) of $3.64B ($95.03 book value per share). Book value represents the net worth of the company belonging to common stock holders.
Baozun Inc. (BZUN) reported a current ratio of 1.87x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.
Key Metrics
Top Statement Risk
Retained losses eroding equity base
Shrinking Assets Mask Deleveraging Progress
Baozun's total assets contracted from $10.5B in 2023Q4 to $9.6B in 2026Q2 while equity fell 12% to $3.6B, driven chiefly by accumulated retained losses reaching -$924.7M, according to recent SEC filings, suggesting a balance sheet shrinking faster than it deleverages.
The simultaneous decline in assets, liabilities, and equity reads less like balance sheet repair and more like gradual contraction, with total liabilities falling from $4.6B to $4.1B alongside the equity erosion. Investors should note that the headline debt reduction is partly offset by the fact that the retained earnings deficit deepened by roughly $419M over the same span, implying the deleveraging has been funded by asset liquidation or depreciation rather than earnings accumulation, which would be a meaningfully different quality signal.
Conservative Leverage Amid Cash Drawdown
Total debt declined from $2.8B to $2.1B over ten quarters, lifting the debt-to-equity ratio from 0.47 to 0.38, per Baozun's reported balance sheet, a reduction that appears strategically driven rather than forced given the current ratio remains near 1.90.
A D/E of 0.38 positions Baozun well below its peers VNET (3.29) and CANG (1.41), suggesting management has prioritized balance sheet conservatism even as profitability remained strained. However, because cash simultaneously fell from $2.3B to $1.3B while debt was being repaid, the deleveraging may be drawing on the company's liquidity reservoir rather than operating cash generation, which warrants monitoring given only one quarter of disclosed operating cash flow data. The absence of disclosed maturity schedules in the supplied data leaves refinancing risk difficult to assess directly.
Retained Losses Erode Equity Base
Equity slipped from $4.1B to $3.6B as retained earnings deepened from -$506.0M to -$924.7M, and with only $10.2M of buybacks across the period, based on Baozun's balance sheet disclosures, the erosion appears driven by operating losses rather than shareholder distributions.
The retained earnings deficit growing by nearly 83% over ten quarters while equity fell a much smaller 12% suggests other equity components—potentially reserves or translation adjustments—have partially cushioned the reported book value, meaning headline equity may overstate the internally generated capital base. This dynamic aligns with the prior income statement finding of a razor-thin 0.6% net margin and cumulative losses, and implies that any apparent equity stability rests on non-earnings line items investors should decompose further. Cumulative stock-based compensation of roughly $130M noted in cash flow analysis may also be suppressing the pace of equity growth through dilution even as it never appears as a cash outflow.
Cash Buffer Thins Against Current Ratio Drift
Cash fell 43% from $2.3B in 2023Q4 to $1.3B in 2026Q2 while the current ratio eased from 2.10 to 1.90, according to Baozun's reported figures, leaving a still-substantial but visibly narrowing liquidity buffer against operating volatility.
Even at $1.3B of cash against $4.1B of total liabilities, the near-term coverage position appears adequate, particularly with a current ratio that has not breached 1.87 across the entire ten-quarter window. The concern is directional rather than absolute: cash has now declined for three consecutive readings from the $1.6B level in 2024Q4, and if this trajectory persists alongside the deepening retained losses, the liquidity cushion could tighten faster than the slowly drifting current ratio implies. Given that cash flow disclosure is limited to a single quarter, investors should treat the implied cash runway as provisional pending fuller statement visibility.
Goodwill and PPE Write-Downs Distort Asset Quality
Goodwill fell from $369.4M to $274.4M and net PPE declined from $1.9B to $1.3B over the period, per the company's quarterly filings, a combined asset contraction that may indicate write-downs outpacing reinvestment and could flatter return metrics computed on a shrinking asset base.
The 26% goodwill reduction concentrated between 2025Q1 and 2025Q4 looks consistent with impairment activity rather than divestiture, though the supplied data does not distinguish between the two, and the simultaneous 30% PPE contraction appears difficult to reconcile with the modest $106.5M capex reported in the only disclosed spending period. This matters because ROIC and asset turnover ratios calculated against a shrinking denominator would mechanically improve without any corresponding gain in operating productivity. Combined with the prior cash flow finding that capital deployment to shareholders was negligible, the pattern suggests the balance sheet may be shrinking through non-cash charges rather than strategic repositioning—a distinction that could materially alter how an analyst reads the improving D/E ratio.